Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins

Amyloid deposits are primarily composed of the amyloid-beta protein, although other proteins (and metal ions) also have been colocalized to these lesions. The pattern of oxidative modifications in amyloid plaques is very different to that associated with neurofibrillary tangles and neuronal cell bodies, likely reflecting the different composition of these structures, accessibility of oxidants, the generation of oxidants in and around these structures and the intrinsic antioxidant defense systems to protect these structures. Future studies directed at understanding Abeta interactions with other amyloid components, the role of oxidative modifications in stabilizing amyloid deposits and the determination of protease cleavage sites on Abeta may provide mechanistic insights regarding both amyloid formation and removal.

[1]  R. Kalaria,et al.  Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects , 2004, Acta Neuropathologica.

[2]  C. Geula,et al.  Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles , 1987, Annals of neurology.

[3]  Khadija Iqbal,et al.  Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia , 2004, Acta Neuropathologica.

[4]  W. Griffin,et al.  Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution , 1995, Neuropathology and applied neurobiology.

[5]  Ashley I. Bush,et al.  Redox-active iron mediates amyloid-β toxicity , 2001 .

[6]  E. Masliah,et al.  Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. , 1995, Biochemistry.

[7]  S. Ju,et al.  Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[8]  E M Wijsman,et al.  A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.

[9]  R N Kalaria,et al.  Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease , 1995, Journal of neurochemistry.

[10]  E. Perry,et al.  ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE , 1986, The Lancet.

[11]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[12]  D. Nochlin,et al.  Identification and Immunolocalization of a New Class of Proteoglycan (Keratan Sulfate) to the Neuritic Plaques of Alzheimer's Disease , 1996, Experimental Neurology.

[13]  B. Shapiro,et al.  Release of ovoperoxidase from sea urchin eggs hardens the fertilization membrane with tyrosine crosslinks. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Hyman,et al.  Quantitation of apoE Domains in Alzheimer Disease Brain Suggests a Role for apoE in Aß Aggregation , 2001, Journal of neuropathology and experimental neurology.

[15]  R. Kalaria,et al.  Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders , 1991, Neuropathology and applied neurobiology.

[16]  E. Masliah,et al.  Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease , 1999, Experimental Neurology.

[17]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[18]  G. Irvine,et al.  Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins. , 2000, Journal of structural biology.

[19]  P. Mantyh,et al.  Brain Amyloid — A Physicochemical Perspective , 1996, Brain pathology.

[20]  D. Graham,et al.  βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.

[21]  T. Benzinger,et al.  Two-Dimensional Structure of β-Amyloid(10−35) Fibrils† , 2000 .

[22]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[23]  G. Perry,et al.  Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .

[24]  R. Scott,et al.  Processing of the beta-amyloid precursor. Multiple proteases generate and degrade potentially amyloidogenic fragments. , 1993, The Journal of biological chemistry.

[25]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[26]  A. Peters,et al.  The Structure of Neuritic Plaques in the Cerebral Cortex of Aged Rats , 1981, Journal of neuropathology and experimental neurology.

[27]  D. Mann,et al.  Dominant and differential deposition of distinct β-amyloid peptide species, Aβ N3(pE), in senile plaques , 1995, Neuron.

[28]  S. Arlt,et al.  Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma , 2001 .

[29]  S. Squazzo,et al.  Aggregation of Secreted Amyloid -Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture (*) , 1995, The Journal of Biological Chemistry.

[30]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[31]  P. Fraser,et al.  An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.

[32]  S. Mirra,et al.  Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly Racemized , 1988, Journal of neurochemistry.

[33]  Min Xu,et al.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Geula,et al.  Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue , 1991, Brain Research.

[35]  D. Allsop,et al.  The isolation and amino acid composition of senile plaque core protein , 1983, Brain Research.

[36]  B. Hyman,et al.  Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.

[37]  P. Cras,et al.  Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  J. Wegiel,et al.  Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines * , 1996, Neuropathology and applied neurobiology.

[39]  A. Scheibel,et al.  Immunodetection of the amyloid P component in Alzheimer's disease , 2004, Acta Neuropathologica.

[40]  H. Kresse,et al.  Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  D. Perl,et al.  Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.

[42]  D. Price,et al.  Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. , 1995, The American journal of pathology.

[43]  P. Lansbury,et al.  Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. , 1990, Biochemistry.

[44]  N. Robakis,et al.  Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .

[45]  B. Corain Alzheimer's disease : advances in clinical and basic research , 1993 .

[46]  H. Chui,et al.  Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease , 1990, Brain Research.

[47]  R. Tanzi,et al.  Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. , 1999, Metal ions in biological systems.

[48]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[49]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[50]  S. Styren,et al.  Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.

[51]  S M Breathnach,et al.  Amyloid and amyloidosis. , 1988, Journal of the American Academy of Dermatology.

[52]  U. Schreiter-Gasser,et al.  Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices , 1991, FEBS letters.

[53]  R. Nixon,et al.  Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.

[54]  K. Beyreuther,et al.  Amyloidogenicity of rodent and human βA4 sequences , 1993 .

[55]  E. Masliah,et al.  Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. , 1996, The American journal of pathology.

[56]  C. Geula,et al.  Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease , 1989, Brain Research.

[57]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[58]  W. Markesbery,et al.  N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.

[59]  G. Perry,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[61]  B. Hyman,et al.  Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice , 2000, Acta Neuropathologica.

[62]  Y. Takahashi,et al.  Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J). , 1992, Journal of biochemistry.

[63]  R. Martins,et al.  Anti-apoptotic action of Alzheimer Ab , 1999 .

[64]  G. Perry,et al.  Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease , 1993, Brain Research.

[65]  C. Masters,et al.  Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.

[66]  M. Yoshimoto,et al.  NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  P. Briza,et al.  Candida albicans cell walls contain the fluorescent cross-linking amino acid dityrosine , 1995, Infection and immunity.

[68]  D. Selkoe,et al.  Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1 , 2000, Nature Cell Biology.

[69]  Eric J. Simon,et al.  Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide , 1995, Nature Structural Biology.

[70]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[71]  E. Bird,et al.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.

[72]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[73]  W. Griffin,et al.  Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression , 1996, Neuropathology and applied neurobiology.

[74]  J. Silver,et al.  Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease , 1998, Experimental Neurology.

[75]  H. Vinters,et al.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. , 1990, The American journal of pathology.

[76]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[77]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[78]  D. Beauchemin,et al.  A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. , 1998, Analytical chemistry.

[79]  G. Perry,et al.  α1-Trypsin Immunoreactivity in Alzheimer Disease , 1993 .

[80]  B T Hyman,et al.  Growth Arrest of Individual Senile Plaques in a Model of Alzheimer's Disease Observed by In Vivo Multiphoton Microscopy , 2001, The Journal of Neuroscience.

[81]  B. Winblad,et al.  Alzheimer's disease : advances in etiology, pathogenesis, and therapeutics , 2001 .

[82]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[83]  R. Strohmeyer,et al.  Molecular and cellular mediators of Alzheimer's disease inflammation. , 2001, Journal of Alzheimer's disease : JAD.

[84]  T. Wight,et al.  Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses , 1989, Neurobiology of Aging.

[85]  M. Smith,et al.  Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? , 1999, Free radical biology & medicine.

[86]  F. Shimizu,et al.  Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique , 1975, Acta Neuropathologica.

[87]  L. Haverkamp,et al.  Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain , 1995, Neurochemistry International.

[88]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[89]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[90]  P. Lansbury,et al.  The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.

[91]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[92]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[93]  D. Holtzman,et al.  α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related Protein , 1997 .

[94]  R. Mrak,et al.  Correlation of Astrocytic S100β Expression with Dystrophic Neurites in Amyloid Plaques of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[95]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[96]  H. Vinters,et al.  Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy , 1990, Annals of neurology.

[97]  D. Munoz,et al.  Role of microglia in senile plaque formation , 1995, Neurobiology of Aging.

[98]  H. Yamaguchi,et al.  Microglial activation in early stages of amyloid β protein deposition , 1997, Acta Neuropathologica.

[99]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[100]  R. Martins,et al.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease , 1988, Neurology.

[101]  Brian J Cummings,et al.  β-Amyloid converts an acute phase injury response to chronic injury responses , 1996, Neurobiology of Aging.

[102]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[103]  G. Perry,et al.  Microglia are associated with the extracellular neurofibrillary tangles of alzheimer disease , 1991, Brain Research.

[104]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Mcgeer,et al.  Activation of the classical complement pathway in brain tissue of Alzheimer patients , 1989, Neuroscience Letters.

[106]  R. Kalaria,et al.  Factors Affecting Pro- and Anti-Oxidant Properties of Fragments of the b-Protein Precursor (bPP): Implication for Alzheimer's Disease. , 2000, Journal of Alzheimer's disease : JAD.

[107]  R. Tanzi,et al.  Copper catalyzed oxidation of Alzheimer Abeta. , 2000, Cellular and molecular biology.

[108]  P. S. St George-Hyslop,et al.  Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins* , 1997, The Journal of Biological Chemistry.

[109]  J. Silver,et al.  Chondroitin Sulfate Proteoglycans Are Associated with the Lesions of Alzheimer's Disease , 1993, Experimental Neurology.

[110]  T. Iwatsubo,et al.  Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.

[111]  M J Ball,et al.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.

[112]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[113]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[114]  T. Wight,et al.  Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .

[115]  G. Perry,et al.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.

[116]  L. Goodman Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. , 1953, The Journal of nervous and mental disease.

[117]  C. Franceschi,et al.  In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[118]  R. Kalaria,et al.  Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease , 1990, Brain Research.

[119]  Y. Ihara,et al.  Appearance of Sodium Dodecyl Sulfate-Stable Amyloid β-Protein (Aβ) Dimer in the Cortex During Aging , 1999 .

[120]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[121]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[122]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[123]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[124]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[125]  P. Greengard,et al.  Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[126]  B. Sommer,et al.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice. , 1999, The American journal of pathology.

[127]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[128]  P. Lewitt,et al.  Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders , 1996, Brain Research.

[129]  Y. Ihara,et al.  Ubiquitin is a component of paired helical filaments in Alzheimer's disease. , 1987, Science.

[130]  S. Younkin,et al.  Amyloid β protein (Aβ) removal by neuroglial cells in culture , 1995, Neurobiology of Aging.

[131]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[132]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[133]  P. Cras,et al.  Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[134]  K. Beyreuther,et al.  Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.

[135]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[136]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[137]  M. Ball,et al.  Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.

[138]  V. Chau,et al.  Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[139]  W. Markesbery,et al.  Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.

[140]  S. Styren,et al.  Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain , 1990, Experimental Neurology.

[141]  R. Mrak,et al.  Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evalution , 1995, Journal of neuropathology and experimental neurology.

[142]  R. Kalaria,et al.  Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease , 1992, Neuroscience.

[143]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[144]  M. Smith,et al.  Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome , 1999, Annals of the New York Academy of Sciences.

[145]  P. Cras,et al.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. , 1990, The American journal of pathology.

[146]  D. Selkoe,et al.  Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. , 1998, Biochemistry.